TY - JOUR A1 - Dreymann, Nico A1 - Wuensche, Julia A1 - Sabrowski, Wiebke A1 - Moeller, Anja A1 - Czepluch, Denise A1 - Vu Van, Dana A1 - Füssel, Susanne A1 - Menger, Marcus M. T1 - Inhibition of Human Urokinase-Type Plasminogen Activator (uPA) Enzyme Activity and Receptor Binding by DNA Aptamers as Potential Therapeutics through Binding to the Different Forms of uPA JF - International journal of molecular sciences N2 - Urokinase-type plasminogen activator is widely discussed as a marker for cancer prognosis and diagnosis and as a target for cancer therapies. Together with its receptor, uPA plays an important role in tumorigenesis, tumor progression and metastasis. In the present study, systematic evolution of ligands by exponential enrichment (SELEX) was used to select single-stranded DNA aptamers targeting different forms of human uPA. Selected aptamers allowed the distinction between HMW-uPA and LMW-uPA, and therefore, presumably, have different binding regions. Here, uPAapt-02-FR showed highly affine binding with a K-D of 0.7 nM for HMW-uPA and 21 nM for LMW-uPA and was also able to bind to pro-uPA with a K-D of 14 nM. Furthermore, no cross-reactivity to mouse uPA or tissue-type plasminogen activator (tPA) was measured, demonstrating high specificity. Suppression of the catalytic activity of uPA and inhibition of uPAR-binding could be demonstrated through binding with different aptamers and several of their truncated variants. Since RNA aptamers are already known to inhibit uPA-uPAR binding and other pathological functions of the uPA system, these aptamers represent a novel, promising tool not only for detection of uPA but also for interfering with the pathological functions of the uPA system by additionally inhibiting uPA activity. KW - biomarker KW - cancer KW - cancer therapy KW - DNA aptamer KW - microscale thermophoresis (MST) KW - SELEX KW - surface plasmon resonance spectroscopy (SPR) KW - uPA KW - uPAR KW - urokinase Y1 - 2022 U6 - https://doi.org/10.3390/ijms23094890 SN - 1661-6596 SN - 1422-0067 VL - 23 IS - 9 PB - MDPI CY - Basel ER - TY - GEN A1 - Christakoudi, Sofia A1 - Pagoni, Panagiota A1 - Ferrari, Pietro A1 - Cross, Amanda J. A1 - Tzoulaki, Ioanna A1 - Muller, David C. A1 - Weiderpass, Elisabete A1 - Freisling, Heinz A1 - Murphy, Neil A1 - Dossus, Laure A1 - Turzanski Fortner, Renee A1 - Agudo, Antonio A1 - Overvad, Kim A1 - Perez-Cornago, Aurora A1 - Key, Timothy J. A1 - Brennan, Paul A1 - Johansson, Mattias A1 - Tjonneland, Anne A1 - Halkjaer, Jytte A1 - Boutron-Ruault, Marie-Christine A1 - Artaud, Fanny A1 - Severi, Gianluca A1 - Kaaks, Rudolf A1 - Schulze, Matthias Bernd A1 - Bergmann, Manuela M. A1 - Masala, Giovanna A1 - Grioni, Sara A1 - Simeon, Vittorio A1 - Tumino, Rosario A1 - Sacerdote, Carlotta A1 - Skeie, Guri A1 - Rylander, Charlotta A1 - Borch, Kristin Benjaminsen A1 - Quiros, J. Ramon A1 - Rodriguez-Barranco, Miguel A1 - Chirlaque, Maria-Dolores A1 - Ardanaz, Eva A1 - Amiano, Pilar A1 - Drake, Isabel A1 - Stocks, Tanja A1 - Haggstrom, Christel A1 - Harlid, Sophia A1 - Ellingjord-Dale, Merete A1 - Riboli, Elio A1 - Tsilidis, Konstantinos K. T1 - Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort T2 - Zweitveröffentlichungen der Universität Potsdam : Mathematisch-Naturwissenschaftliche Reihe N2 - Obesity is a risk factor for several major cancers. Associations of weight change in middle adulthood with cancer risk, however, are less clear. We examined the association of change in weight and body mass index (BMI) category during middle adulthood with 42 cancers, using multivariable Cox proportional hazards models in the European Prospective Investigation into Cancer and Nutrition cohort. Of 241 323 participants (31% men), 20% lost and 32% gained weight (>0.4 to 5.0 kg/year) during 6.9 years (average). During 8.0 years of follow-up after the second weight assessment, 20 960 incident cancers were ascertained. Independent of baseline BMI, weight gain (per one kg/year increment) was positively associated with cancer of the corpus uteri (hazard ratio [HR] = 1.14; 95% confidence interval: 1.05-1.23). Compared to stable weight (+/- 0.4 kg/year), weight gain (>0.4 to 5.0 kg/year) was positively associated with cancers of the gallbladder and bile ducts (HR = 1.41; 1.01-1.96), postmenopausal breast (HR = 1.08; 1.00-1.16) and thyroid (HR = 1.40; 1.04-1.90). Compared to maintaining normal weight, maintaining overweight or obese BMI (World Health Organisation categories) was positively associated with most obesity-related cancers. Compared to maintaining the baseline BMI category, weight gain to a higher BMI category was positively associated with cancers of the postmenopausal breast (HR = 1.19; 1.06-1.33), ovary (HR = 1.40; 1.04-1.91), corpus uteri (HR = 1.42; 1.06-1.91), kidney (HR = 1.80; 1.20-2.68) and pancreas in men (HR = 1.81; 1.11-2.95). Losing weight to a lower BMI category, however, was inversely associated with cancers of the corpus uteri (HR = 0.40; 0.23-0.69) and colon (HR = 0.69; 0.52-0.92). Our findings support avoiding weight gain and encouraging weight loss in middle adulthood. T3 - Zweitveröffentlichungen der Universität Potsdam : Mathematisch-Naturwissenschaftliche Reihe - 1373 KW - BMI change KW - cancer KW - middle adulthood KW - weight gain KW - weight loss Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus4-573609 SN - 1866-8372 IS - 7 ER - TY - JOUR A1 - Jannasch, Franziska A1 - Nickel, Daniela V. A1 - Bergmann, Manuela M. A1 - Schulze, Matthias Bernd T1 - A new evidence-based diet score to capture associations of food consumption and chronic disease risk JF - Nutrients / Molecular Diversity Preservation International (MDPI) N2 - Previously, the attempt to compile German dietary guidelines into a diet score was predominantly not successful with regards to preventing chronic diseases in the EPIC-Potsdam study. Current guidelines were supplemented by the latest evidence from systematic reviews and expert papers published between 2010 and 2020 on the prevention potential of food groups on chronic diseases such as type 2 diabetes, cardiovascular diseases and cancer. A diet score was developed by scoring the food groups according to a recommended low, moderate or high intake. The relative validity and reliability of the diet score, assessed by a food frequency questionnaire, was investigated. The consideration of current evidence resulted in 10 key food groups being preventive of the chronic diseases of interest. They served as components in the diet score and were scored from 0 to 1 point, depending on their recommended intake, resulting in a maximum of 10 points. Both the reliability (r = 0.53) and relative validity (r = 0.43) were deemed sufficient to consider the diet score as a stable construct in future investigations. This new diet score can be a promising tool to investigate dietary intake in etiological research by concentrating on 10 key dietary determinants with evidence-based prevention potential for chronic diseases. KW - diet score KW - dietary guidelines KW - food groups KW - chronic disease KW - type 2 KW - diabetes KW - cardiovascular disease KW - cancer KW - prevention KW - reliability; KW - validity Y1 - 2022 U6 - https://doi.org/10.3390/nu14112359 SN - 2072-6643 VL - 14 IS - 11 PB - MDPI CY - Basel ER - TY - THES A1 - Petrich, Annett T1 - Quantitative fluorescence microscopy methods to investigate molecular interactions and dynamics in living cells T1 - Quantitative Fluoreszenzmikroskopiemethoden zur Untersuchung molekularer Interaktionen und Dynamik in lebenden Zellen N2 - Biomolecules such as proteins and lipids have vital roles in numerous cellular functions, including biomolecule transport, protein functions, cellular homeostasis and biomembrane integrity. Traditional biochemistry methods do not provide precise information about cellular biomolecule distribution and behavior under native environmental conditions since they are not transferable to live cell samples. Consequently, this can lead to inaccuracies in quantifying biomolecule interactions due to potential complexities arising from the heterogeneity of native biomembranes. To overcome these limitations, minimal invasive microscopic techniques, such as fluorescence fluctuation spectroscopy (FFS) in combination with fluorescence proteins (FPs) and fluorescence lipid analogs, have been developed. FFS techniques and membrane property sensors enable the quantification of various parameters, including concentration, dynamics, oligomerization, and interaction of biomolecules in live cell samples. In this work, several FFS approaches and membrane property sensors were implemented and employed to examine biological processes of diverse context. Multi-color scanning fluorescence fluctuation spectroscopy (sFCS) was used the examine protein oligomerization, protein-protein interactions (PPIs) and protein dynamics at the cellular plasma membrane (PM). Additionally, two-color number and brightness (N&B) analysis was extended with the cross-correlation analysis in order to quantify hetero-interactions of proteins in the PM with very slow motion, which would not accessible with sFCS due strong initial photobleaching. Furthermore, two semi-automatic analysis pipelines were designed: spectral Förster resonance energy transfer (FRET) analysis to study changes in membrane charge at the inner leaflet of the PM, and spectral generalized polarization (GP) imaging and spectral phasor analysis to monitor changes in membrane fluidity and order. An important parameter for studying PPIs is molecular brightness, which directly determines oligomerization and can be extracted from FFS data. However, FPs often display complex photophysical transitions, including dark states. Therefore, it is crucial to characterize FPs for their dark-states to ensure reliable oligomerization measurements. In this study, N&B and sFCS analysis were applied to determine photophysical properties of novel green FPs under different conditions (i.e., excitation power and pH) in living cells. The results showed that the new FPs, mGreenLantern (mGL) and Gamillus, exhibited the highest molecular brightness at the cost of lower photostability. The well-established monomeric enhanced green fluorescent protein (mEGFP) remained the best option to investigate PPIs at lower pH, while mGL was best suited for neutral pH, and Gamillus for high pH. These findings provide guidance for selecting an appropriate FP to quantify PPIs via FFS under different environmental conditions. Next, several biophysical fluorescence microscopy approaches (i.e., sFCS, GP imaging, membrane charge FRET) were employed to monitor changes in lipid-lipid-packing in biomembranes in different biological context. Lipid metabolism in cancer cells is known to support rapid proliferation and metastasis. Therefore, targeting lipid synthesis or membrane integrity holds immense promise as an anticancer strategy. However, the mechanism of action of the novel agent erufosine (EPC3) on membrane stability is not fully under stood. The present work revealed that EPC3 reduces lipid packing and composition as well as increased membrane fluidity and dynamic, hence, modifies lipid-lipid-interaction. These effects on membrane integrity were likely triggered by modulations in lipid metabolism and membrane organization. In the case of influenza A virus (IAV) infection, regulation of lipid metabolism is crucial for multiple steps in IAV replication and is related to the pathogenicity of IAV. Here, it is shown for the first time that IAV infection triggers a local enrichment of negatively charged lipids at the inner leaflet of the PM, which decreases membrane fluidity and dynamic, as well as increases lipid packing at the assembly site in living cells. This suggests that IAV alters lipid-lipid interactions and organization at the PM. Overall, this work highlights the potential of biophysical techniques as a screening platform for studying membrane properties in living cells at the single-cell level. Finally, this study addressed remaining questions about the early stage of IAV assembly. The recruitment of matrix protein 1 (M1) and its interaction with other viral surface proteins, hemagglutinin (HA), neuraminidase (NA), and matrix protein 2 (M2), has been a subject of debate due to conflicting results. In this study, different FFS approaches were performed in transfected cells to investigate interactions between IAV proteins themselves and host factors at the PM. FFS measurements revealed that M2 interacts strongly with M1, leading to the translocation of M1 to the PM. This interaction likely took place along the non-canonical pathway, as evidenced by the detection of an interaction between M2 and the host factor LC3-II, leading to the recruitment of LC3-II to the PM. Moreover, weaker interaction was observed between HA and membrane-bound M1, and no interaction between NA and M1. Interestingly, higher oligomeric states of M1 were only detectable in infected cells. These results indicate that M2 initiates virion assembly by recruiting M1 to the PM, which may serve as a platform for further interactions with viral proteins and host factors. N2 - Biomoleküle wie Proteine und Lipide spielen eine wichtige Rolle bei zahlreichen Zellfunktionen, darunter Biomolekültransport, Proteinfunktionen, zelluläre Homöostase und Biomembranintegrität. Traditionelle biochemische Methoden liefern keine Informationen über die Verteilung und das Verhalten zellulärer Biomolekülen unter natürlichen Bedingungen, da sie nicht auf lebende Zellproben übertragbar sind. Folglich kann dies zu Ungenauigkeiten bei der Quantifizierung von Biomolekülinteraktionen führen und potenzielle Komplexitäten der Heterogenität nativer Biomembranen übersehen. Um diese Einschränkungen zu überwinden, wurden minimalinvasive mikroskopische Techniken wie die Fluoreszenzfluktuationsspektroskopie (FFS) in Kombination mit Fluoreszenzproteinen (FPs) und Fluoreszenzlipidanaloga entwickelt. FFS-Techniken und Membraneigenschaftssensoren ermöglichen die Quantifizierung verschiedener Parameter, einschließlich Konzentration, Dynamik, Oligomerisierung und Wechselwirkung von Biomolekülen in lebenden Zellproben. In dieser Arbeit wurden mehrere FFS-Ansätze und Sensoren für Membraneigenschaften implementiert und eingesetzt, um biologische Prozesse in verschiedenen Zusammenhängen zu untersuchen. Die Mehrfarben-Scanning-Fluoreszenzfluktuationsspektroskopie (sFCS) wurde zur Untersuchung von Protein-Oligomerisierung, Protein-Protein-Wechselwirkungen (PPIs) und Proteindynamik an der zellulären Plasmamembran (PM) eingesetzt. Zusätzlich wurde die Zweifarben-Analyse von Anzahl und Helligkeit (N&B) mit der Kreuzkorrelationsanalyse erweitert, um Hetero-Interaktionen von Proteinen in der PM mit sehr langsamer Dynamik zu quantifizieren, die mit sFCS aufgrund starker anfänglicher Bleiche der Fluorophore nicht zugänglich wären. Darüber hinaus wurden zwei halbautomatische Analysepipelines entwickelt: die spektrale Förster-Resonanz-Energie-Transfer (FRET)-Analyse zur Untersuchung von Änderungen der Membranladung auf der Innenseite der PM und die spektrale generalisierte Polarisation (GP)-Bildgebung sowie die spektrale Phasor-Analyse zur Überwachung von Änderungen der Membranfluidität und -ordnung. Ein wichtiger Parameter zur Untersuchung von PPIs ist die molekulare Helligkeit, die die Oligomerisierung direkt bestimmt und aus FFS daten extrahiert werden kann. Allerdings weisen FPs häufig komplexe photophysikalische Übergänge auf, einschließlich nichtfluoreszierender Zustände. Daher ist es von entscheidender Bedeutung, FPs hinsichtlich ihrer dunklen Zustände zu charakterisieren, um zuverlässige Oligomerisierungsmessungen sicherzustellen. In dieser Studie wurden N&B- und sFCS-Analysen angewendet, um die photophysikalischen Eigenschaften neuartiger grüner FPs unter verschiedenen Bedingungen (d. h. Anregungsleistung und pH-Wert) in lebenden Zellen zu bestimmen. Die Ergebnisse zeigten, dass die neuen FPs mGreenLantern (mGL) und Gamillus die höchste molekulare Helligkeit aufwiesen, allerdings auf Kosten einer geringeren Photostabilität. Das etablierte mEGFP blieb die beste Option, um PPIs bei niedrigerem pH-Wert zu untersuchen, während mGL am besten für neutralen pH-Wert und Gamillus für hohen pH-Wert geeignet war. Diese Ergebnisse bieten Orientierung für die Auswahl eines geeigneten FP zur Quantifizierung von PPIs über FFS unter verschiedenen Umgebungsbedingungen. Als nächstes wurden mehrere biophysikalische Fluoreszenzmikroskopie-Ansätze (z. B. sFCS, GP-Bildgebung, Membranladung-FRET) eingesetzt, um Veränderungen in der Lipid-Lipid-Packung in Biomembranen in verschiedenen biologischen Kontexten zu überwachen. Es ist bekannt, dass der Lipidstoffwechsel in Krebszellen die schnelle Vermehrung und Metastasierung fördert. Daher ist die gezielte Beeinflussung der Lipidsynthese oder der Membranintegrität eine vielversprechende Strategie zur Krebsbekämpfung. Der Wirkungsmechanismus des neuartigen Wirkstoffs Erufosin (EPC3) auf die Membranstabilität ist nicht vollständig geklärt. Die vorliegende Arbeit ergab, dass EPC3 die Lipidpackung und -zusammensetzung reduziert sowie die Fluidität und Dynamik der Membran erhöht und somit die Lipid-Lipid-Wechselwirkung verändert. Diese Auswirkungen auf die Membranintegrität wurden wahrscheinlich durch Modulationen des Lipidstoffwechsels und der Membranorganisation ausgelöst. Im Falle einer Infektion mit dem Influenza-A-Virus (IAV) ist die Regulierung des Lipidstoffwechsels für mehrere Schritte der IAV-Replikation von entscheidender Bedeutung und hängt mit der Pathogenität von IAV zusammen. Hier wird zum ersten Mal gezeigt, dass eine IAV-Infektion eine lokale Anreicherung negativ geladener Lipide an der Innenseite der PM auslöst, die Fluidität und Dynamik der Membran verringert und die Lipidpackung an der Assemblierungsstelle in lebenden Zellen erhöht. Dies legt nahe, dass IAV die Lipid-Lipid-Wechselwirkungen und die Organisation am PM verändert. Insgesamt unterstreicht diese Arbeit das Potenzial biophysikalischer Techniken als Screening-Plattform zur Untersuchung von Membraneigenschaften in lebenden Zellen auf Einzelzellebene. Abschließend ging diese Studie auf verbleibende Fragen zur frühen Phase der IAV-Assemblierung ein. Die Rekrutierung von Matrixprotein 1 (M1) und seine Wechselwirkung mit anderen viralen Oberflächenproteinen, Hämagglutinin (HA), Neuraminidase (NA) und Matrixprotein 2 (M2), war aufgrund widersprüchlicher Ergebnisse Gegenstand von Debatten. In dieser Studie wurden verschiedene FFS-Ansätze in transfizierten Zellen durchgeführt, um Wechselwirkungen zwischen IAV-Proteinen untereinander und Wirtsfaktoren an der PM zu untersuchen. FFS-Messungen ergaben, dass M2 stark mit M1 interagiert, was zur Translokation von M1 zur PM führt. Diese Interaktion fand wahrscheinlich entlang des nichtkanonischen Weges statt, was durch den Nachweis einer Interaktion zwischen M2 und dem Wirtsfaktor LC3-II belegt wurde, die zur Rekrutierung von LC3-II zur PM führte. Darüber hinaus wurde eine schwächere Wechselwirkung zwischen HA und membrangebundenem M1 beobachtet und keine Wechselwirkung zwischen NA und M1. Interessanterweise waren höhere oligomere Zustände von M1 nur in infizierten Zellen nachweisbar. Diese Ergebnisse deuten darauf hin, dass M2 den Zusammenbau von Virionen initiiert, indem es M1 zur PM rekrutiert, welches als Plattform für weitere Interaktionen mit viralen Proteinen und Wirtsfaktoren dienen könnte. KW - influenza A virus KW - virus-host interaction KW - cancer KW - biomolecule interactions KW - membrane fluidity KW - fluorescence fluctuation spectroscopy KW - fluorescent proteins KW - biosensors KW - Biomolekülinteraktionen KW - Biosensoren KW - Krebs KW - Fluoreszenzfluktuationsspektroskopie KW - fluoreszierende Proteine KW - Influenza A Virus KW - Membranfluidität KW - Virus-Wirt-Interaktion Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus4-611800 ER - TY - JOUR A1 - Kangas, Maria A1 - Heissel, Andreas T1 - Mental health literacy, treatment preferences and the lived experience of mental health problems in an Australian cancer sample JF - Psycho-oncology N2 - Objectives: The prevalence rates for mental health (MH) problems in cancer patients is high, although reduced uptake of services may be influenced by mental health literacy (MHL). The objective of this study was to investigate the MHL for depression and panic disorder (PD), including treatment preferences in Australian adults who had been diagnosed and treated for cancer, and whether MHL and treatment preferences was influenced by sex, age, and individuals' lived MH experience. Method: A total of 421 cancer survivors (n = 378 females) completed a self-report survey. Participants were asked to specify whether they had a lived experience with anxiety and/or depression, and to indicate treatment preferences for managing cancer-related distress. Two vignettes were administered to assess MHL for depression and PD. Results: The MHL accuracy for depression was higher than PD. Accuracy rates were higher for females with a lived experience with anxiety and/or depression; although the accuracy rate for PD was significantly lower in males. A high proportion of individuals preferred exercise and in-person counselling to manage depression and PD. Internet-based therapies were not strongly preferred for managing MH problems. Conclusions: The MHL for depression and PD is moderate for adult cancer survivors, with higher levels indicated for individuals with a personal lived experience with anxiety and/or depression. Public health campaigns for enhancing MHL should broaden to include individuals experiencing comorbid physical health conditions. Health providers also need to take into account client preferences for evidence-based therapies. KW - anxiety KW - cancer KW - exercise KW - major depression KW - mental health KW - preferences KW - psycho-oncology KW - treatment Y1 - 2020 U6 - https://doi.org/10.1002/pon.5520 SN - 1057-9249 SN - 1099-1611 VL - 29 IS - 11 SP - 1883 EP - 1894 PB - Wiley CY - New York, NY ER - TY - JOUR A1 - Christakoudi, Sofia A1 - Pagoni, Panagiota A1 - Ferrari, Pietro A1 - Cross, Amanda J. A1 - Tzoulaki, Ioanna A1 - Muller, David C. A1 - Weiderpass, Elisabete A1 - Freisling, Heinz A1 - Murphy, Neil A1 - Dossus, Laure A1 - Turzanski Fortner, Renee A1 - Agudo, Antonio A1 - Overvad, Kim A1 - Perez-Cornago, Aurora A1 - Key, Timothy J. A1 - Brennan, Paul A1 - Johansson, Mattias A1 - Tjonneland, Anne A1 - Halkjaer, Jytte A1 - Boutron-Ruault, Marie-Christine A1 - Artaud, Fanny A1 - Severi, Gianluca A1 - Kaaks, Rudolf A1 - Schulze, Matthias Bernd A1 - Bergmann, Manuela M. A1 - Masala, Giovanna A1 - Grioni, Sara A1 - Simeon, Vittorio A1 - Tumino, Rosario A1 - Sacerdote, Carlotta A1 - Skeie, Guri A1 - Rylander, Charlotta A1 - Borch, Kristin Benjaminsen A1 - Quiros, J. Ramon A1 - Rodriguez-Barranco, Miguel A1 - Chirlaque, Maria-Dolores A1 - Ardanaz, Eva A1 - Amiano, Pilar A1 - Drake, Isabel A1 - Stocks, Tanja A1 - Häggström, Christel A1 - Harlid, Sophia A1 - Ellingjord-Dale, Merete A1 - Riboli, Elio A1 - Tsilidis, Konstantinos K. T1 - Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort JF - International journal of cancer N2 - Obesity is a risk factor for several major cancers. Associations of weight change in middle adulthood with cancer risk, however, are less clear. We examined the association of change in weight and body mass index (BMI) category during middle adulthood with 42 cancers, using multivariable Cox proportional hazards models in the European Prospective Investigation into Cancer and Nutrition cohort. Of 241 323 participants (31% men), 20% lost and 32% gained weight (>0.4 to 5.0 kg/year) during 6.9 years (average). During 8.0 years of follow-up after the second weight assessment, 20 960 incident cancers were ascertained. Independent of baseline BMI, weight gain (per one kg/year increment) was positively associated with cancer of the corpus uteri (hazard ratio [HR] = 1.14; 95% confidence interval: 1.05-1.23). Compared to stable weight (+/- 0.4 kg/year), weight gain (>0.4 to 5.0 kg/year) was positively associated with cancers of the gallbladder and bile ducts (HR = 1.41; 1.01-1.96), postmenopausal breast (HR = 1.08; 1.00-1.16) and thyroid (HR = 1.40; 1.04-1.90). Compared to maintaining normal weight, maintaining overweight or obese BMI (World Health Organisation categories) was positively associated with most obesity-related cancers. Compared to maintaining the baseline BMI category, weight gain to a higher BMI category was positively associated with cancers of the postmenopausal breast (HR = 1.19; 1.06-1.33), ovary (HR = 1.40; 1.04-1.91), corpus uteri (HR = 1.42; 1.06-1.91), kidney (HR = 1.80; 1.20-2.68) and pancreas in men (HR = 1.81; 1.11-2.95). Losing weight to a lower BMI category, however, was inversely associated with cancers of the corpus uteri (HR = 0.40; 0.23-0.69) and colon (HR = 0.69; 0.52-0.92). Our findings support avoiding weight gain and encouraging weight loss in middle adulthood. KW - BMI change KW - cancer KW - middle adulthood KW - weight gain KW - weight loss Y1 - 2020 U6 - https://doi.org/10.1002/ijc.33339 SN - 0020-7136 SN - 1097-0215 VL - 148 IS - 7 SP - 1637 EP - 1651 PB - Wiley CY - Hoboken ER - TY - GEN A1 - Kühne, Franziska A1 - Hermann, Myriel A1 - Preisler, Martina A1 - Rohrmoser, Amy A1 - Letsch, Anne A1 - Goerling, Ute T1 - Prognostic Awareness in Advanced Disease BT - A Review Update and Concept Analysis T2 - Postprints der Universität Potsdam : Humanwissenschaftliche Reihe N2 - Purpose: Although subjective knowledge about the prognosis of an advanced disease is extremely important for coping and treatment planning, the concept of prognostic awareness (PA) remains inconsistently defined. The aims of the scoping review were to synthesize a definition of PA from the most recent literature, describe preconditions, correlates and consequences, and suggest a conceptual model. Methods: By using scoping review methodology, we searched the Web of Science and PubMed databases, and included publications, reviews, meta-analyses or guidelines on all physical diagnoses, as well as publications offering a conceptual or an operational definition of PA. The data were analyzed by means of content analysis techniques. Results: Of the 24 included publications, 21 referred exclusively to cancer, one to patients with hip fractures and two to palliative care in general. The deduced definition of PA comprised the following facets: adequate estimation of chances for recovery, knowledge of limited time to live, adequate estimation of life expectancy, knowledge of therapy goals, and knowledge of the course of the disease. Further content analysis results were mapped graphically and in a detailed table. Conclusion: There appears to be a lack of theoretical embedding of PA that in turn influences the methods used for empirical investigation. Drawing on a clear conceptual definition, longitudinal or experimental studies would be desirable. T3 - Zweitveröffentlichungen der Universität Potsdam : Humanwissenschaftliche Reihe - 745 KW - prognosis KW - advanced disease KW - cancer KW - oncology KW - palliative care KW - patient-centered care KW - systematic review Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus4-542829 SN - 1866-8364 ER - TY - JOUR A1 - Kühne, Franziska A1 - Hermann, Myriel A1 - Preisler, Martina A1 - Rohrmoser, Amy A1 - Letsch, Anne A1 - Goerling, Ute T1 - Prognostic Awareness in Advanced Disease BT - A Review Update and Concept Analysis JF - Frontiers in Psychology N2 - Purpose: Although subjective knowledge about the prognosis of an advanced disease is extremely important for coping and treatment planning, the concept of prognostic awareness (PA) remains inconsistently defined. The aims of the scoping review were to synthesize a definition of PA from the most recent literature, describe preconditions, correlates and consequences, and suggest a conceptual model. Methods: By using scoping review methodology, we searched the Web of Science and PubMed databases, and included publications, reviews, meta-analyses or guidelines on all physical diagnoses, as well as publications offering a conceptual or an operational definition of PA. The data were analyzed by means of content analysis techniques. Results: Of the 24 included publications, 21 referred exclusively to cancer, one to patients with hip fractures and two to palliative care in general. The deduced definition of PA comprised the following facets: adequate estimation of chances for recovery, knowledge of limited time to live, adequate estimation of life expectancy, knowledge of therapy goals, and knowledge of the course of the disease. Further content analysis results were mapped graphically and in a detailed table. Conclusion: There appears to be a lack of theoretical embedding of PA that in turn influences the methods used for empirical investigation. Drawing on a clear conceptual definition, longitudinal or experimental studies would be desirable. KW - prognosis KW - cancer KW - oncology KW - palliative care KW - patient-centered care KW - systematic review KW - advanced disease Y1 - 2020 U6 - https://doi.org/10.3389/fpsyg.2021.629050 SN - 1664-1078 VL - 12 PB - Frontiers Research Foundation CY - Lausanne ER - TY - JOUR A1 - Guo, Ranran A1 - Tian, Ye A1 - Yang, Yueqi A1 - Jiang, Qin A1 - Wang, Yajun A1 - Yang, Wuli T1 - A Yolk-Shell nanoplatform for gene-silencing-enhanced photolytic ablation of cancer JF - Advanced functional materials N2 - Noninvasive near-infrared (NIR) light responsive therapy is a promising cancer treatment modality; however, some inherent drawbacks of conventional phototherapy heavily restrict its application in clinic. Rather than producing heat or reactive oxygen species in conventional NIR treatment, here a multifunctional yolk-shell nanoplatform is proposed that is able to generate microbubbles to destruct cancer cells upon NIR laser irradiation. Besides, the therapeutic effect is highly improved through the coalition of small interfering RNA (siRNA), which is codelivered by the nanoplatform. In vitro experiments demonstrate that siRNA significantly inhibits expression of protective proteins and reduces the tolerance of cancer cells to bubble-induced environmental damage. In this way, higher cytotoxicity is achieved by utilizing the yolk-shell nanoparticles than treated with the same nanoparticles missing siRNA under NIR laser irradiation. After surface modification with polyethylene glycol and transferrin, the yolk-shell nanoparticles can target tumors selectively, as demonstrated from the photoacoustic and ultrasonic imaging in vivo. The yolk-shell nanoplatform shows outstanding tumor regression with minimal side effects under NIR laser irradiation. Therefore, the multifunctional nanoparticles that combining bubble-induced mechanical effect with RNA interference are expected to be an effective NIR light responsive oncotherapy. KW - cancer KW - gene silencing KW - near-infrared absorption KW - photolytic ablation KW - yolk-shell nanoparticles Y1 - 2018 U6 - https://doi.org/10.1002/adfm.201706398 SN - 1616-301X SN - 1616-3028 VL - 28 IS - 14 PB - Wiley-VCH CY - Weinheim ER - TY - JOUR A1 - Galbete, Cecilia A1 - Kröger, Janine A1 - Jannasch, Franziska A1 - Iqbal, Khalid A1 - Schwingshackl, Lukas A1 - Schwedhelm, Carolina A1 - Weikert, Cornelia A1 - Boeing, Heiner A1 - Schulze, Matthias Bernd T1 - Nordic diet, Mediterranean diet, and the risk of chronic diseases BT - the EPIC-Potsdam study JF - BMC Medicine N2 - Background: The Mediterranean Diet (MedDiet) has been acknowledged as a healthy diet. However, its relation with risk of major chronic diseases in non-Mediterranean countries is inconclusive. The Nordic diet is proposed as an alternative across Northern Europe, although its associations with the risk of chronic diseases remain controversial. We aimed to investigate the association between the Nordic diet and the MedDiet with the risk of chronic disease (type 2 diabetes (T2D), myocardial infarction (MI), stroke, and cancer) in the EPIC-Potsdam cohort. Methods: The EPIC-Potsdam cohort recruited 27,548 participants between 1994 and 1998. After exclusion of prevalent cases, we evaluated baseline adherence to a score reflecting the Nordic diet and two MedDiet scores (tMDS, reflecting the traditional MedDiet score, and the MedPyr score, reflecting the MedDiet Pyramid). Cox regression models were applied to examine the association between the diet scores and the incidence of major chronic diseases. Results: During a follow-up of 10.6 years, 1376 cases of T2D, 312 of MI, 321 of stroke, and 1618 of cancer were identified. The Nordic diet showed a statistically non-significant inverse association with incidence of MI in the overall population and of stroke in men. Adherence to the MedDiet was associated with lower incidence of T2D (HR per 1 SD 0.93, 95% CI 0.88-0.98 for the tMDS score and 0.92, 0.87-0.97 for the MedPyr score). In women, the MedPyr score was also inversely associated with MI. No association was observed for any of the scores with cancer. Conclusions: In the EPIC-Potsdam cohort, the Nordic diet showed a possible beneficial effect on MI in the overall population and for stroke in men, while both scores reflecting the MedDiet conferred lower risk of T2D in the overall population and of MI in women. KW - Mediterranean diet KW - Nordic diet KW - regional diets KW - chronic diseases KW - diabetes KW - myocardial infarction KW - stroke KW - cancer KW - EPIC-Potsdam study KW - longitudinal analysis Y1 - 2018 U6 - https://doi.org/10.1186/s12916-018-1082-y SN - 1741-7015 VL - 16 PB - BMC CY - London ER -